A woman with the rarest type of porphyria, called congenital erythropoietic porphyria or CEP, was…
Steve Bryson, PhD
Steve holds a PhD in biochemistry from the Faculty of Medicine at the University of Toronto, Canada. As a medical scientist for 18 years, he worked in both academia and industry, where his research focused on the discovery of new vaccines and medicines to treat inflammatory disorders and infectious diseases. Steve is a published author in multiple peer-reviewed scientific journals and a patented inventor.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Steve Bryson, PhD
People with variegate porphyria (VP), one of a group of related disorders,…
Radiation therapy for a woman with vaginal cancer completely resolved co-existing porphyria cutanea tarda…
Establishing normal urinary levels of delta-aminolevulinic acid (ALA) and porphobilinogen…
Panhematin (hemin for injection), an approved medication to treat acute intermittent porphyria…
The U.S. incidence of the most common form of liver cancer — called hepatocellular carcinoma…
People with acute intermittent porphyria (AIP) who were treated with…
Two previously unreported mutations were found in a man and his mother with variegate porphyria…